nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—esophageal cancer	0.813	1	CbGaD
Lomitapide—Antrafenine—PTGS1—esophageal cancer	0.00495	0.568	CrCbGaD
Lomitapide—Hepatic steatosis—Capecitabine—esophageal cancer	0.00408	0.0323	CcSEcCtD
Lomitapide—Abdominal pain lower—Capecitabine—esophageal cancer	0.00388	0.0306	CcSEcCtD
Lomitapide—Blood potassium decreased—Capecitabine—esophageal cancer	0.00324	0.0256	CcSEcCtD
Lomitapide—Prothrombin level increased—Capecitabine—esophageal cancer	0.003	0.0237	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—esophageal cancer	0.00283	0.325	CrCbGaD
Lomitapide—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00275	0.0217	CcSEcCtD
Lomitapide—Proctalgia—Capecitabine—esophageal cancer	0.00263	0.0208	CcSEcCtD
Lomitapide—Joint swelling—Capecitabine—esophageal cancer	0.00251	0.0199	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—CRTC1—esophageal cancer	0.0024	0.0464	CbGpPWpGaD
Lomitapide—Hepatotoxicity—Cisplatin—esophageal cancer	0.00217	0.0171	CcSEcCtD
Lomitapide—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00214	0.0414	CbGpPWpGaD
Lomitapide—Infection—Carboplatin—esophageal cancer	0.00202	0.016	CcSEcCtD
Lomitapide—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00183	0.0144	CcSEcCtD
Lomitapide—Laryngeal pain—Capecitabine—esophageal cancer	0.00181	0.0143	CcSEcCtD
Lomitapide—Haematemesis—Capecitabine—esophageal cancer	0.00177	0.014	CcSEcCtD
Lomitapide—Hepatomegaly—Capecitabine—esophageal cancer	0.00174	0.0138	CcSEcCtD
Lomitapide—Blister—Capecitabine—esophageal cancer	0.00171	0.0135	CcSEcCtD
Lomitapide—Rash erythematous—Capecitabine—esophageal cancer	0.00161	0.0127	CcSEcCtD
Lomitapide—Body temperature increased—Carboplatin—esophageal cancer	0.00161	0.0127	CcSEcCtD
Lomitapide—Hepatotoxicity—Capecitabine—esophageal cancer	0.0016	0.0126	CcSEcCtD
Lomitapide—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00136	0.0108	CcSEcCtD
Lomitapide—Nasal congestion—Cisplatin—esophageal cancer	0.00133	0.0105	CcSEcCtD
Lomitapide—Haematemesis—Methotrexate—esophageal cancer	0.00132	0.0104	CcSEcCtD
Lomitapide—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00132	0.0255	CbGpPWpGaD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00131	0.0254	CbGpPWpGaD
Lomitapide—Blood bilirubin increased—Capecitabine—esophageal cancer	0.0013	0.0103	CcSEcCtD
Lomitapide—Gait disturbance—Capecitabine—esophageal cancer	0.00126	0.00998	CcSEcCtD
Lomitapide—Hepatotoxicity—Methotrexate—esophageal cancer	0.00119	0.00939	CcSEcCtD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00117	0.0226	CbGpPWpGaD
Lomitapide—Dehydration—Cisplatin—esophageal cancer	0.00113	0.00892	CcSEcCtD
Lomitapide—Ecchymosis—Capecitabine—esophageal cancer	0.00111	0.00881	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00109	0.00864	CcSEcCtD
Lomitapide—Nasopharyngitis—Cisplatin—esophageal cancer	0.00109	0.00858	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—GHRL—esophageal cancer	0.00104	0.0202	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00104	0.0202	CbGpPWpGaD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00104	0.0202	CbGpPWpGaD
Lomitapide—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00103	0.00813	CcSEcCtD
Lomitapide—Gastroenteritis—Capecitabine—esophageal cancer	0.00101	0.00798	CcSEcCtD
Lomitapide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00101	0.00795	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00097	0.00767	CcSEcCtD
Lomitapide—Increased appetite—Capecitabine—esophageal cancer	0.000952	0.00753	CcSEcCtD
Lomitapide—Fexofenadine—ABCB1—esophageal cancer	0.000939	0.108	CrCbGaD
Lomitapide—Dermatitis bullous—Capecitabine—esophageal cancer	0.000936	0.0074	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.000915	0.0177	CbGpPWpGaD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.000912	0.0177	CbGpPWpGaD
Lomitapide—Pain in extremity—Capecitabine—esophageal cancer	0.000895	0.00707	CcSEcCtD
Lomitapide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000885	0.00699	CcSEcCtD
Lomitapide—Migraine—Capecitabine—esophageal cancer	0.000881	0.00696	CcSEcCtD
Lomitapide—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.000841	0.0163	CbGpPWpGaD
Lomitapide—Dehydration—Capecitabine—esophageal cancer	0.000832	0.00658	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—esophageal cancer	0.00083	0.00656	CcSEcCtD
Lomitapide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000829	0.00655	CcSEcCtD
Lomitapide—Liver function test abnormal—Capecitabine—esophageal cancer	0.000826	0.00653	CcSEcCtD
Lomitapide—Connective tissue disorder—Cisplatin—esophageal cancer	0.000825	0.00652	CcSEcCtD
Lomitapide—Urethral disorder—Cisplatin—esophageal cancer	0.000823	0.0065	CcSEcCtD
Lomitapide—Dry skin—Capecitabine—esophageal cancer	0.00082	0.00648	CcSEcCtD
Lomitapide—Abdominal pain upper—Capecitabine—esophageal cancer	0.000817	0.00646	CcSEcCtD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000808	0.0157	CbGpPWpGaD
Lomitapide—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000806	0.00637	CcSEcCtD
Lomitapide—Nasopharyngitis—Capecitabine—esophageal cancer	0.0008	0.00632	CcSEcCtD
Lomitapide—Gastritis—Capecitabine—esophageal cancer	0.000792	0.00626	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000789	0.00624	CcSEcCtD
Lomitapide—Eye disorder—Cisplatin—esophageal cancer	0.000785	0.0062	CcSEcCtD
Lomitapide—Cardiac disorder—Cisplatin—esophageal cancer	0.000779	0.00616	CcSEcCtD
Lomitapide—Abdominal distension—Capecitabine—esophageal cancer	0.000778	0.00615	CcSEcCtD
Lomitapide—Influenza—Capecitabine—esophageal cancer	0.000773	0.00611	CcSEcCtD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.000771	0.015	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Cisplatin—esophageal cancer	0.000757	0.00598	CcSEcCtD
Lomitapide—Angina pectoris—Capecitabine—esophageal cancer	0.000753	0.00595	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000753	0.0146	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000753	0.0146	CbGpPWpGaD
Lomitapide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000741	0.00586	CcSEcCtD
Lomitapide—Malnutrition—Cisplatin—esophageal cancer	0.000731	0.00578	CcSEcCtD
Lomitapide—Flatulence—Cisplatin—esophageal cancer	0.00072	0.00569	CcSEcCtD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00072	0.014	CbGpPWpGaD
Lomitapide—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000704	0.0137	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000704	0.0136	CbGpPWpGaD
Lomitapide—Muscle spasms—Cisplatin—esophageal cancer	0.000703	0.00555	CcSEcCtD
Lomitapide—Weight decreased—Capecitabine—esophageal cancer	0.0007	0.00553	CcSEcCtD
Lomitapide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.000698	0.0135	CbGpPWpGaD
Lomitapide—Infestation NOS—Capecitabine—esophageal cancer	0.000689	0.00545	CcSEcCtD
Lomitapide—Infestation—Capecitabine—esophageal cancer	0.000689	0.00545	CcSEcCtD
Lomitapide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000678	0.00536	CcSEcCtD
Lomitapide—Anaemia—Cisplatin—esophageal cancer	0.000676	0.00534	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000671	0.013	CbGpPWpGaD
Lomitapide—Malaise—Cisplatin—esophageal cancer	0.000659	0.00521	CcSEcCtD
Lomitapide—Haematuria—Capecitabine—esophageal cancer	0.000657	0.0052	CcSEcCtD
Lomitapide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000652	0.00515	CcSEcCtD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000642	0.0125	CbGpPWpGaD
Lomitapide—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000641	0.0124	CbGpPWpGaD
Lomitapide—Myalgia—Cisplatin—esophageal cancer	0.000622	0.00492	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000618	0.00488	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—esophageal cancer	0.000615	0.00486	CcSEcCtD
Lomitapide—Discomfort—Cisplatin—esophageal cancer	0.000615	0.00486	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000614	0.0119	CbGpPWpGaD
Lomitapide—Urinary tract disorder—Capecitabine—esophageal cancer	0.000611	0.00483	CcSEcCtD
Lomitapide—Connective tissue disorder—Capecitabine—esophageal cancer	0.000608	0.00481	CcSEcCtD
Lomitapide—Urethral disorder—Capecitabine—esophageal cancer	0.000607	0.00479	CcSEcCtD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000604	0.0117	CbGpPWpGaD
Lomitapide—Infection—Cisplatin—esophageal cancer	0.000593	0.00468	CcSEcCtD
Lomitapide—Nervous system disorder—Cisplatin—esophageal cancer	0.000585	0.00462	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—NOS2—esophageal cancer	0.000585	0.0113	CbGpPWpGaD
Lomitapide—Skin disorder—Cisplatin—esophageal cancer	0.000579	0.00458	CcSEcCtD
Lomitapide—Eye disorder—Capecitabine—esophageal cancer	0.000578	0.00457	CcSEcCtD
Lomitapide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000577	0.00456	CcSEcCtD
Lomitapide—Cardiac disorder—Capecitabine—esophageal cancer	0.000574	0.00454	CcSEcCtD
Lomitapide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000563	0.0109	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Capecitabine—esophageal cancer	0.000558	0.00441	CcSEcCtD
Lomitapide—Chills—Capecitabine—esophageal cancer	0.000555	0.00439	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000552	0.00436	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC52A3—esophageal cancer	0.000546	0.0106	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BLVRB—esophageal cancer	0.000546	0.0106	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000544	0.0043	CcSEcCtD
Lomitapide—Malnutrition—Capecitabine—esophageal cancer	0.000539	0.00426	CcSEcCtD
Lomitapide—Paraesthesia—Cisplatin—esophageal cancer	0.000536	0.00423	CcSEcCtD
Lomitapide—Flatulence—Capecitabine—esophageal cancer	0.000531	0.0042	CcSEcCtD
Lomitapide—Back pain—Capecitabine—esophageal cancer	0.000521	0.00412	CcSEcCtD
Lomitapide—Decreased appetite—Cisplatin—esophageal cancer	0.000519	0.0041	CcSEcCtD
Lomitapide—Muscle spasms—Capecitabine—esophageal cancer	0.000518	0.00409	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000515	0.00407	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—esophageal cancer	0.000513	0.00406	CcSEcCtD
Lomitapide—Infestation—Methotrexate—esophageal cancer	0.000513	0.00406	CcSEcCtD
Lomitapide—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000505	0.00979	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Capecitabine—esophageal cancer	0.0005	0.00395	CcSEcCtD
Lomitapide—Anaemia—Capecitabine—esophageal cancer	0.000498	0.00394	CcSEcCtD
Lomitapide—Feeling abnormal—Cisplatin—esophageal cancer	0.000492	0.00388	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—esophageal cancer	0.000489	0.00387	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000488	0.00946	CbGpPWpGaD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000486	0.00942	CbGpPWpGaD
Lomitapide—Malaise—Capecitabine—esophageal cancer	0.000486	0.00384	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000485	0.00384	CcSEcCtD
Lomitapide—Vertigo—Capecitabine—esophageal cancer	0.000484	0.00383	CcSEcCtD
Lomitapide—Palpitations—Capecitabine—esophageal cancer	0.000476	0.00376	CcSEcCtD
Lomitapide—Body temperature increased—Cisplatin—esophageal cancer	0.000472	0.00373	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC10A2—esophageal cancer	0.000464	0.009	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CA1—esophageal cancer	0.000464	0.009	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000464	0.00899	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000464	0.00899	CbGpPWpGaD
Lomitapide—Chest pain—Capecitabine—esophageal cancer	0.000459	0.00363	CcSEcCtD
Lomitapide—Arthralgia—Capecitabine—esophageal cancer	0.000459	0.00363	CcSEcCtD
Lomitapide—Myalgia—Capecitabine—esophageal cancer	0.000459	0.00363	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000456	0.0036	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000455	0.0036	CcSEcCtD
Lomitapide—Discomfort—Capecitabine—esophageal cancer	0.000453	0.00358	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—esophageal cancer	0.000452	0.00357	CcSEcCtD
Lomitapide—Dry mouth—Capecitabine—esophageal cancer	0.000449	0.00355	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000443	0.00859	CbGpPWpGaD
Lomitapide—Infection—Capecitabine—esophageal cancer	0.000437	0.00345	CcSEcCtD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000434	0.00841	CbGpPWpGaD
Lomitapide—Nervous system disorder—Capecitabine—esophageal cancer	0.000431	0.00341	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—esophageal cancer	0.000431	0.0034	CcSEcCtD
Lomitapide—Asthenia—Cisplatin—esophageal cancer	0.000428	0.00338	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—esophageal cancer	0.000428	0.00338	CcSEcCtD
Lomitapide—Skin disorder—Capecitabine—esophageal cancer	0.000427	0.00338	CcSEcCtD
Lomitapide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000425	0.00336	CcSEcCtD
Lomitapide—MTTP—Metabolism—CA2—esophageal cancer	0.000424	0.00823	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Methotrexate—esophageal cancer	0.000415	0.00328	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000415	0.00804	CbGpPWpGaD
Lomitapide—Chills—Methotrexate—esophageal cancer	0.000413	0.00327	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000413	0.00801	CbGpPWpGaD
Lomitapide—Diarrhoea—Cisplatin—esophageal cancer	0.000408	0.00323	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—esophageal cancer	0.000401	0.00317	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000401	0.00317	CcSEcCtD
Lomitapide—Paraesthesia—Capecitabine—esophageal cancer	0.000395	0.00312	CcSEcCtD
Lomitapide—MTTP—Metabolism—PLCE1—esophageal cancer	0.000395	0.00765	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ADH7—esophageal cancer	0.000395	0.00765	CbGpPWpGaD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000392	0.00759	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00039	0.00756	CbGpPWpGaD
Lomitapide—Back pain—Methotrexate—esophageal cancer	0.000388	0.00307	CcSEcCtD
Lomitapide—Dyspepsia—Capecitabine—esophageal cancer	0.000387	0.00306	CcSEcCtD
Lomitapide—Decreased appetite—Capecitabine—esophageal cancer	0.000382	0.00302	CcSEcCtD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000382	0.0074	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00038	0.003	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—esophageal cancer	0.000379	0.003	CcSEcCtD
Lomitapide—Fatigue—Capecitabine—esophageal cancer	0.000379	0.003	CcSEcCtD
Lomitapide—Constipation—Capecitabine—esophageal cancer	0.000376	0.00297	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000372	0.00294	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—esophageal cancer	0.000371	0.00293	CcSEcCtD
Lomitapide—Feeling abnormal—Capecitabine—esophageal cancer	0.000362	0.00286	CcSEcCtD
Lomitapide—Malaise—Methotrexate—esophageal cancer	0.000362	0.00286	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—esophageal cancer	0.00036	0.00285	CcSEcCtD
Lomitapide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00036	0.00284	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—EP300—esophageal cancer	0.000358	0.00693	CbGpPWpGaD
Lomitapide—Nausea—Cisplatin—esophageal cancer	0.000354	0.0028	CcSEcCtD
Lomitapide—Body temperature increased—Capecitabine—esophageal cancer	0.000348	0.00275	CcSEcCtD
Lomitapide—Abdominal pain—Capecitabine—esophageal cancer	0.000348	0.00275	CcSEcCtD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000347	0.00672	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ADH1B—esophageal cancer	0.000346	0.00671	CbGpPWpGaD
Lomitapide—Chest pain—Methotrexate—esophageal cancer	0.000341	0.0027	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—esophageal cancer	0.000341	0.0027	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—esophageal cancer	0.000341	0.0027	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000339	0.00268	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—esophageal cancer	0.000337	0.00267	CcSEcCtD
Lomitapide—MTTP—Metabolism—TYMP—esophageal cancer	0.000331	0.00641	CbGpPWpGaD
Lomitapide—Infection—Methotrexate—esophageal cancer	0.000325	0.00257	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP26A1—esophageal cancer	0.000322	0.00624	CbGpPWpGaD
Lomitapide—Nervous system disorder—Methotrexate—esophageal cancer	0.000321	0.00254	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—esophageal cancer	0.000318	0.00251	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000316	0.0025	CcSEcCtD
Lomitapide—Asthenia—Capecitabine—esophageal cancer	0.000316	0.00249	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALOX15—esophageal cancer	0.000314	0.00608	CbGpPWpGaD
Lomitapide—Diarrhoea—Capecitabine—esophageal cancer	0.000301	0.00238	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000299	0.0058	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TPI1—esophageal cancer	0.000299	0.0058	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTO1—esophageal cancer	0.000299	0.0058	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000298	0.00236	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000294	0.00571	CbGpPWpGaD
Lomitapide—Paraesthesia—Methotrexate—esophageal cancer	0.000294	0.00232	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000293	0.00568	CbGpPWpGaD
Lomitapide—Somnolence—Methotrexate—esophageal cancer	0.000291	0.0023	CcSEcCtD
Lomitapide—Dizziness—Capecitabine—esophageal cancer	0.000291	0.0023	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000291	0.00563	CbGpPWpGaD
Lomitapide—Dyspepsia—Methotrexate—esophageal cancer	0.000288	0.00228	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALDOB—esophageal cancer	0.000287	0.00556	CbGpPWpGaD
Lomitapide—Decreased appetite—Methotrexate—esophageal cancer	0.000285	0.00225	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000283	0.00223	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—esophageal cancer	0.000282	0.00223	CcSEcCtD
Lomitapide—Vomiting—Capecitabine—esophageal cancer	0.00028	0.00221	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000276	0.00535	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GAPDH—esophageal cancer	0.000276	0.00535	CbGpPWpGaD
Lomitapide—Headache—Capecitabine—esophageal cancer	0.000275	0.00218	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000274	0.00532	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CRABP1—esophageal cancer	0.000274	0.0053	CbGpPWpGaD
Lomitapide—Feeling abnormal—Methotrexate—esophageal cancer	0.00027	0.00213	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000268	0.00212	CcSEcCtD
Lomitapide—Nausea—Capecitabine—esophageal cancer	0.000261	0.00206	CcSEcCtD
Lomitapide—MTTP—Metabolism—GNG7—esophageal cancer	0.00026	0.00504	CbGpPWpGaD
Lomitapide—Abdominal pain—Methotrexate—esophageal cancer	0.000259	0.00205	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—esophageal cancer	0.000259	0.00205	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000257	0.00498	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—esophageal cancer	0.000256	0.00496	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALDH2—esophageal cancer	0.000244	0.00473	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000239	0.00463	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000238	0.0046	CbGpPWpGaD
Lomitapide—Asthenia—Methotrexate—esophageal cancer	0.000235	0.00186	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTT1—esophageal cancer	0.000232	0.0045	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00023	0.00446	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2A6—esophageal cancer	0.000229	0.00444	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000228	0.00443	CbGpPWpGaD
Lomitapide—Diarrhoea—Methotrexate—esophageal cancer	0.000224	0.00177	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000219	0.00425	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000218	0.00423	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ENO1—esophageal cancer	0.000217	0.00421	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS1—esophageal cancer	0.000217	0.00421	CbGpPWpGaD
Lomitapide—Dizziness—Methotrexate—esophageal cancer	0.000216	0.00171	CcSEcCtD
Lomitapide—MTTP—Metabolism—PSME1—esophageal cancer	0.000214	0.00415	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PSME2—esophageal cancer	0.000214	0.00415	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00021	0.00407	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000209	0.00406	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000209	0.00405	CbGpPWpGaD
Lomitapide—Vomiting—Methotrexate—esophageal cancer	0.000208	0.00164	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000207	0.00401	CbGpPWpGaD
Lomitapide—Headache—Methotrexate—esophageal cancer	0.000205	0.00162	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000197	0.00381	CbGpPWpGaD
Lomitapide—Nausea—Methotrexate—esophageal cancer	0.000194	0.00154	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000187	0.00362	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1B1—esophageal cancer	0.000185	0.00358	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000184	0.00358	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000181	0.00351	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP19A1—esophageal cancer	0.000174	0.00337	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000171	0.00332	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00017	0.0033	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000169	0.00328	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000167	0.00324	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000161	0.00313	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000159	0.00308	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HMOX1—esophageal cancer	0.000159	0.00307	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000157	0.00304	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000156	0.00302	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000156	0.00302	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000156	0.00301	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCB1—esophageal cancer	0.000152	0.00295	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.00014	0.00271	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000137	0.00266	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000136	0.00264	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000129	0.0025	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000127	0.00246	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000125	0.00243	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000125	0.00242	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000122	0.00236	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000118	0.00229	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000116	0.00225	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000115	0.00223	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000115	0.00222	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000109	0.00211	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000108	0.0021	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000105	0.00204	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000102	0.00198	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CREBBP—esophageal cancer	0.000102	0.00197	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.66e-05	0.00187	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	9.61e-05	0.00186	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	9.53e-05	0.00185	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	9.24e-05	0.00179	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.22e-05	0.00179	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	9.14e-05	0.00177	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NOS3—esophageal cancer	9.1e-05	0.00176	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	9.04e-05	0.00175	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	8.95e-05	0.00174	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.84e-05	0.00171	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.84e-05	0.00171	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	8.57e-05	0.00166	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8.47e-05	0.00164	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—esophageal cancer	8.33e-05	0.00161	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	7.28e-05	0.00141	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	7.18e-05	0.00139	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—EP300—esophageal cancer	6.93e-05	0.00134	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	6.85e-05	0.00133	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.75e-05	0.00131	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.7e-05	0.0013	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.08e-05	0.00118	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.01e-05	0.00116	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.98e-05	0.00116	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.97e-05	0.00116	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BLVRB—esophageal cancer	5.97e-05	0.00116	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.16e-05	0.001	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—esophageal cancer	5.12e-05	0.000993	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.08e-05	0.000984	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA1—esophageal cancer	5.08e-05	0.000984	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.01e-05	0.000971	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.9e-05	0.00095	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA2—esophageal cancer	4.64e-05	0.0009	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.43e-05	0.000858	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADH7—esophageal cancer	4.32e-05	0.000837	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLCE1—esophageal cancer	4.32e-05	0.000837	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.28e-05	0.00083	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.07e-05	0.00079	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADH1B—esophageal cancer	3.79e-05	0.000734	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.7e-05	0.000718	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.68e-05	0.000713	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.68e-05	0.000713	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TYMP—esophageal cancer	3.62e-05	0.000701	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.55e-05	0.000688	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.52e-05	0.000682	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.47e-05	0.000673	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALOX15—esophageal cancer	3.43e-05	0.000665	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TPI1—esophageal cancer	3.27e-05	0.000634	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTO1—esophageal cancer	3.27e-05	0.000634	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDOB—esophageal cancer	3.14e-05	0.000608	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA1—esophageal cancer	3.13e-05	0.000606	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.13e-05	0.000606	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GAPDH—esophageal cancer	3.02e-05	0.000585	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.01e-05	0.000584	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CRABP1—esophageal cancer	2.99e-05	0.00058	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.92e-05	0.000565	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA2—esophageal cancer	2.86e-05	0.000555	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNG7—esophageal cancer	2.85e-05	0.000552	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDH2—esophageal cancer	2.67e-05	0.000517	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADH7—esophageal cancer	2.66e-05	0.000516	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.66e-05	0.000516	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—esophageal cancer	2.54e-05	0.000492	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.51e-05	0.000486	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS1—esophageal cancer	2.38e-05	0.000461	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO1—esophageal cancer	2.38e-05	0.000461	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.38e-05	0.00046	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSME2—esophageal cancer	2.34e-05	0.000454	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSME1—esophageal cancer	2.34e-05	0.000454	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.33e-05	0.000452	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TYMP—esophageal cancer	2.23e-05	0.000432	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.17e-05	0.00042	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.11e-05	0.00041	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.02e-05	0.000392	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.02e-05	0.000391	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TPI1—esophageal cancer	2.02e-05	0.000391	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.93e-05	0.000375	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.9e-05	0.000368	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.86e-05	0.000361	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.84e-05	0.000357	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNG7—esophageal cancer	1.75e-05	0.00034	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMOX1—esophageal cancer	1.73e-05	0.000336	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.64e-05	0.000319	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.56e-05	0.000303	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.55e-05	0.0003	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO1—esophageal cancer	1.46e-05	0.000284	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.46e-05	0.000284	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSME1—esophageal cancer	1.44e-05	0.00028	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSME2—esophageal cancer	1.44e-05	0.00028	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.25e-05	0.000241	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.17e-05	0.000227	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CREBBP—esophageal cancer	1.11e-05	0.000216	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.07e-05	0.000207	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.03e-05	0.000199	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NOS3—esophageal cancer	9.96e-06	0.000193	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—esophageal cancer	9.11e-06	0.000177	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—EP300—esophageal cancer	7.58e-06	0.000147	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.85e-06	0.000133	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NOS3—esophageal cancer	6.14e-06	0.000119	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.61e-06	0.000109	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.61e-06	0.000109	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—EP300—esophageal cancer	4.67e-06	9.05e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.45e-06	6.69e-05	CbGpPWpGaD
